Full Text View
Tabular View
No Study Results Posted
Related Studies
XIENCE V® Everolimus Eluting Coronary Stent System India Post-Marketing Registry (XIENCE V India)
This study is ongoing, but not recruiting participants.
Study NCT00631228   Information provided by Abbott Vascular
First Received: February 28, 2008   Last Updated: June 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Disease
Coronary Artery Disease
Coronary Restenosis
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Coronary Stenosis
Heart Diseases
Myocardial Ischemia
Vascular Diseases
Additional drug interventions recognized in this trial
Everolimus
More general drug interventions related to this trial
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Abbott Vascular


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services